Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics

EyePoint Pharmaceuticals (EYPT) reported $14.03 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 33.2$0.33 for the same period compares to -$0.61 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$8.71 million, representing a surprise of +61.00%. The company delivered an EPS surprise of +45.00%, with the consensus EPS estimate being -$0.60.While investors scrutinize revenue and earnings changes year-over-year and how they ...